Bateman A - Search Results

1

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.

Ahmed A, Jevremovic D, Suzuki K, Kottke T, Thompson J, Emery S, Harrington K, Bateman A, Vile R. Ahmed A, et al. Among authors: bateman a. Gene Ther. 2003 Sep;10(19):1663-71. doi: 10.1038/sj.gt.3302064. Gene Ther. 2003. PMID: 12923565

2

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. Bateman AR, et al. Cancer Res. 2002 Nov 15;62(22):6566-78. Cancer Res. 2002. PMID: 12438252

3

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.

Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ, Vile RG. Diaz RM, et al. Among authors: bateman a. Gene Ther. 2000 Oct;7(19):1656-63. doi: 10.1038/sj.gt.3301277. Gene Ther. 2000. PMID: 11083474

4

Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.

Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ. Higuchi H, et al. Among authors: bateman a. Cancer Res. 2000 Nov 15;60(22):6396-402. Cancer Res. 2000. PMID: 11103804

5

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.

Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ. Galanis E, et al. Among authors: bateman a. Hum Gene Ther. 2001 May 1;12(7):811-21. doi: 10.1089/104303401750148766. Hum Gene Ther. 2001. PMID: 11339897

6

A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.

Emiliusen L, Gough M, Bateman A, Ahmed A, Voellmy R, Chester J, Diaz RM, Harrington K, Vile R. Emiliusen L, et al. Among authors: bateman a. Gene Ther. 2001 Jul;8(13):987-98. doi: 10.1038/sj.gt.3301470. Gene Ther. 2001. PMID: 11438833

7

Gene therapy for prostate cancer: current status and future prospects.

Harrington KJ, Spitzweg C, Bateman AR, Morris JC, Vile RG. Harrington KJ, et al. Among authors: bateman ar. J Urol. 2001 Oct;166(4):1220-33. doi: 10.1016/s0022-5347(05)65742-4. J Urol. 2001. PMID: 11547047 Review.

8

Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Linardakis E, et al. Among authors: bateman a. Cancer Res. 2002 Oct 1;62(19):5495-504. Cancer Res. 2002. PMID: 12359759

9

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines.

Phan V, Errington F, Cheong SC, Kottke T, Gough M, Altmann S, Brandenburger A, Emery S, Strome S, Bateman A, Bonnotte B, Melcher A, Vile R. Phan V, et al. Among authors: bateman a. Nat Med. 2003 Sep;9(9):1215-9. doi: 10.1038/nm923. Epub 2003 Aug 17. Nat Med. 2003. PMID: 12925849

10

Cancer gene therapy: Part 1. Vector development and regulation of gene expression.

Harrington KJ, Bateman AR, Melcher AA, Ahmed A, Vile RG. Harrington KJ, et al. Among authors: bateman ar. Clin Oncol (R Coll Radiol). 2002 Feb;14(1):3-16. doi: 10.1053/clon.2001.0002. Clin Oncol (R Coll Radiol). 2002. PMID: 11898782 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

943 results

Search Page

Filters